Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability

Table 4 The total costs of MS, in euros per patient per year, for the sample studied (N = 200) according to disability.

total costs (direct + indirect)	14327	18837	27869	41198	52841	*24272*
EDSS	0	1.0–3.0	3.5–5.5	6.0–7.0	7.5–9.5	mean
% patients on IM treatment our MS Unit	6	57	41	47	4	31
total costs adjusted by % of patients on IT in our MS Unit	7400	17589	23157	40273	48729	*19589*
% of global costs attributable to IT, in MS Unit	9	43	21	14	1	19
Disability -according to EDSS-	mild		moderate		severe
Global costs of MS in Poland (Orlewska et al., 2005)	6572		9362		11078
"Italy (Amato et al, 2002)	7463		23088		35975
"Sweden (Heriksson et al., 2001)	18787		36470		91986
"Germany (Kobelt et al., 2000)	20000		39000		61000
"United Kingdom (Kobelt et al., 2000)	20000		38000		41500
"France (Murphy et al., 1998)	8000		16000		22400
"Germany (Murphy et al., 1998)	9088		8224		22804
"United Kingdom (Murphy et al., 1998)	20500		27004		58488

Costs were calculated for patients classified in the 5 EDSS groups (columns 1 to 5) and for the whole sample, N = 200, (column 6). The total costs were adjusted by the percentage of patients on IT (immunomodulatory treatment) in our MS Unit in 2004. Costs that have been reported in other countries have been converted into euros and are described below (also according to patients' disability).

ISSN: 1472-6963